- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07620795
Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
THE EFFECT OF WEB-BASED EDUCATION GIVEN TO WOMEN ON THEIR ATTITUDES AND BELIEFS ABOUT HPV TESTING
Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing.
Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: MERVE İÇÖZ, Phd Student, Msc Midwife
- Telefonnummer: +905072094020
- E-post: merve.icoz@ogr.sakarya.edu.tr
Studera Kontakt Backup
- Namn: ZEKİYE TURAN, Phd, Associate Professor
- Telefonnummer: +905055376788
- E-post: zekiyeturan@sakarya.edu.tr
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Having no prior clinical diagnosis of cervical cancer
- Being between 18 and 60 years of age
- Having active access to the internet
- Being literate at a level sufficient to read and understand the questionnaire forms
- Being capable of effectively navigating and using a web browser
- Being registered as a patient at Sakarya Akyazı No. 3 Family Health Center
- Volunteering to participate in the study and providing informed consent
Exclusion Criteria:
- Withdrawing from the study voluntarily at any stage
- Failing to watch the mandatory educational videos on the platform
- Submitting incomplete or incorrect responses to the data collection tools
- Lacking active internet access or proper web browser usage skills
Criteria for Study Discontinuation / Drop-out:
- Participant's request to withdraw from the study
- Failure to respond to or complete the data collection tools
- Not using or logging into the web application for more than 2 consecutive weeks during the study period
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Intervention Group
Participants in this group will receive access to the web-based health education platform developed for the study.
|
Participants in the intervention group will receive health education through a specially designed web-based platform containing 11 presentations in total (8 PowerPoint presentations, 1 animation video explaining how the HPV test is performed, and 1 researcher-led instructional video demonstrating self-vulvar examination on a model).
Participants will also be provided with educational brochures and magnets.
For participants who do not view the presentations, weekly reminder text messages will be sent to encourage platform login and module completion.
|
|
Inget ingripande: control group
Participants in this group will receive standard routine follow-up during the study.
After the completion of the study data collection, the web-based health education platform will also be made accessible to this group.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale
Tidsram: Baseline and 12 weeks post-intervention
|
This subscale consists of 7 items (items 1-7) assessing personal barriers, stigma, and shame related to HPV testing.
Scores range from 7 to 49.
A higher score indicates a higher level of perceived personal barriers, meaning a less favorable attitude toward HPV testing.
|
Baseline and 12 weeks post-intervention
|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Social Norms Subscale
Tidsram: Baseline and 12 weeks post-intervention
|
This subscale consists of 4 items (items 8-11) assessing the influence of friends, partners, family, and social media on HPV testing.
Scores range from 4 to 28.
A higher score indicates higher negative social pressure/barriers, meaning a lower level of favorable attitudes and beliefs
|
Baseline and 12 weeks post-intervention
|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Trust Subscale
Tidsram: Baseline and 12 weeks post-intervention
|
This subscale consists of 6 items (items 12-17) assessing trust in the healthcare system, accuracy of HPV testing, and medical procedures.
Scores range from 6 to 42.
A higher score indicates higher levels of perceived benefit, confidence, and trust toward HPV testing.
|
Baseline and 12 weeks post-intervention
|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Concerns Subscale
Tidsram: Baseline and 12 weeks post-intervention
|
This subscale consists of 3 items (items 18-20) assessing concerns and worries related to the process and outcomes of HPV testing.
Scores range from 3 to 21.
A higher score indicates higher levels of concerns/negative attitudes toward HPV testing.
|
Baseline and 12 weeks post-intervention
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studiestol: ZEKİYE TURAN, Phd, Associate Professor, Sakarya University Faculty of Health Sciences
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Urogenitala sjukdomar
- Genitala sjukdomar
- Urogenitala neoplasmer
- Neoplasmer efter plats
- Neoplasmer
- Kvinnliga urogenitala sjukdomar
- Kvinnliga urogenitala sjukdomar och graviditetskomplikationer
- Livmodersjukdomar
- Genitala sjukdomar, kvinnor
- Genitala neoplasmer, hona
- Livmoderhalssjukdomar
- Uterina neoplasmer
- Behandlingsefterlevnad och efterlevnad
- Hälsobeteende
- Patientefterlevnad
- Patientacceptans av hälso- och sjukvård
- Vidhäftningsinsatser
- Medicinering vidhäftning
- Uterina cervikala neoplasmer
- Beteende
- Hälsoutbildning
Andra studie-ID-nummer
- SAU-SBE-MI-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .